Ole Schmiedel

Dr. Ole Schmiedel

orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2019 in The Lancet
Verified
Journal Article
Closed access
HGHertzel C Gerstein
Hertzel C Gerstein
HCHelen M Colhoun
Helen M Colhoun
GDGilles R Dagenais
Gilles R Dagenais
RDRafael Diaz
Rafael Diaz
MLMark Lakshmanan
Mark Lakshmanan
WZWilliam Zigrang
William Zigrang

1 July 2019 in The Lancet
Verified
Journal Article
Closed access
HGHertzel C Gerstein
Hertzel C Gerstein
HCHelen M Colhoun
Helen M Colhoun
GDGilles R Dagenais
Gilles R Dagenais
RDRafael Diaz
Rafael Diaz
MLMark Lakshmanan
Mark Lakshmanan
WZWilliam Zigrang
William Zigrang

1 December 2007 in American Journal of Physiology-Heart and Circulatory Physiology
Verified
Journal Article
Closed access
PDF file
OSOle Schmiedel
Ole Schmiedel
MSMatthias L. Schroeter
Matthias L. Schroeter
JHJohn N. Harvey
John N. Harvey
Vascular oscillation (vasomotion) occurs in the microcirculation and is thought to be a significant contributor to tissue perfusion. Our aims were to assess the relationship of vasomotion to perfusion in the cutaneous microcirculation of diabetic patients, to determine the influence on it of endothelium-dependent and nonendothelium-dependent vasodilatory stimuli, and to assess the relationship to perfusion and vasomotion of various biochemical markers of vascular function (HbA1c, LDL- and HDL-cholesterol, triglycerides, insulin resistance, high sensitive C-reactive protein, L- and E-selectin, soluble ICAM, von Willebrand factor) and microalbuminuria. Perfusion and vasomotion (spectral density at low and very low frequencies) were measured by laser-Doppler flowmetry after local heat and iontophoresis of ACh and sodium nitroprusside. Perfusion responses to all stimuli were impaired in patients with Type 2 diabetes (heat: F = 28.0, P < 0.001; ACh: F = 7.11, P = 0.003; sodium nitroprusside: F = 4.0, P = 0.028). Responses to endothelium-dependent stimuli were further impaired in microalbuminuric patients (heat: P = 0.035; ACh: P = 0.034). Vasomotion responses at low frequencies after endothelium-dependent stimuli were impaired in diabetic patients compared with that shown in controls (heat: F = 5.62, P = 0.002; ACh: F = 4.32, P = 0.015). Multivariate modeling showed microalbuminuria to be the only consistent predictor of perfusion and vasomotion responses. The results suggest that microalbuminuria in Type 2 diabetes reflects a generalized disturbance of microvascular function related to endothelium-dependent mechanisms.

31 August 2008 in Microvascular Research
Verified
Journal Article
Closed access
OSOle Schmiedel
Ole Schmiedel
TNTuro J. Nurmikko
Turo J. Nurmikko
MSMatthias L. Schroeter
Matthias L. Schroeter
RWRhiannon Whitaker
Rhiannon Whitaker
JHJohn N. Harvey
John N. Harvey

14 December 2021 in BMJ Open
Verified
Journal Article
Open access
PDF file
NRNishanthan Ramachandran
Nishanthan Ramachandran
OSOle Schmiedel
Ole Schmiedel
EVEhsan Vaghefi
Ehsan Vaghefi
SHSophie Hill
Sophie Hill
GWGraham Wilson
Graham Wilson
DSDavid Squirrell
David Squirrell
Objectives To evaluate the prevalence of incidental non-diabetic ocular comorbidities detected at first screen in a large diabetic retinopathy (DR) screening programme. Design Cross-sectional cohort study. Setting Single large metropolitan diabetic eye screening programme in Auckland, New Zealand. Participants Twenty-two thousand seven hundred and seventy-one participants who attended screening from September 2008 to August 2018. Results Hypertensive retinopathy (HTR) was observed in 14.2% (3236/22 771) participants. Drusen were present in 14.0% participants under the age of 55 years, increasing to 20.5% in those 55 years and older. The prevalence of neovascular age-related macular degeneration (AMD) was 0.5% in participants aged75 years. Retinal vein occlusion and retinal arterial embolus were prevalent in 0.7% and 0.02%, respectively, in participants aged75 years. Cataracts were common being present in 37.1% of participants over the age of 75 years. Only 386 individuals (1.7%) were labelled as glaucoma suspects. Geographic atrophy, epiretinal membrane, choroidal nevi and posterior capsular opacification had an increased prevalence in older individuals. Conclusions Our data suggest that AMD, HTR and cataracts are routinely detected during DR screening. The incorporation of the detection of these ocular comorbidities during DR screening provide opportunities for patients to modify risk factors (smoking cessation and diet for AMD, blood pressure for HTR) and allow access to cataract surgery.

1 July 2011 in Microvascular Research
Verified
Journal Article
Closed access
DPDimitris Parthimos
Dimitris Parthimos
OSOle Schmiedel
Ole Schmiedel
JHJohn N. Harvey
John N. Harvey
TGTudor M. Griffith
Tudor M. Griffith